Skip to main content
. 2020 Nov 26;116(5):1233–1244. doi: 10.1111/add.15295

Table 2.

Association of the timing of the COVID‐19 lockdown with smoking and quitting behaviour in England

% (95% CI) OR (95% CI) P ORadj (95% CI) P
Smoking prevalencea
Before 15.9 (15.4–16.4) 1.00 f
After 17.0 (15.2–18.9) 1.09 (0.95–1.24) 0.228
Cessationb
Before 4.1 (3.4–4.9) 1.00 1.00
After 8.8 (6.0–12.4) 2.28 (1.50–3.47) < 0.001 2.63 (1.69–4.09) < 0.001
Quit attemptsb
Before 29.1 (27.5–30.7) 1.00 1.00
After 39.6 (34.2–45.1) 1.61 (1.27–2.03) < 0.001 1.56 (1.23–1.98) < 0.001
Quit successc
Before 13.9 (11.7–16.3) 1.00 1.00
After 21.3 (14.5–29.4) 1.71 (1.08–2.72) 0.023 2.01 (1.22–3.33) 0.007
Use of evidence‐based supportc , d
Before 51.5 (48.1–54.8) 1.00 1.00
After 50.0 (41.0–59.0) 0.94 (0.65–1.36) 0.748 1.10 (0.72–1.68) 0.647
Use of remote supportc , e
Before 2.7 (1.7–4.0) 1.00 1.00
After 10.9 (6.1–17.7) 4.23 (2.12–8.46) < 0.001 3.59 (1.56–8.23) 0.003

All data are weighted to match the adult population in England on age, social grade, region, tenure, ethnicity and working status within sex.

CI = confidence interval; OR = unadjusted odds ratio; ORadj = odds ratio adjusted for age, sex, social grade, region (and, for analyses of cessation, quit success and use of support, heaviness of smoking index). Before, April 2019–February 2020; after, April 2020.

a

Among all adults (before n = 18 880, after n = 1670);

b

among past‐year smokers (before n = 3165, after n = 329);

c

among past‐year smokers who made a quit attempt (before n = 894, after n = 128);

d

prescription medication, face‐to‐face behavioural support, nicotine replacement therapy obtained over the counter, e‐cigarettes;

e

telephone support, websites or apps;

f

No adjusted analysis was performed for smoking prevalence.